{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:45:26Z","timestamp":1768549526235,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ahj.2017.04.015","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T19:01:46Z","timestamp":1493838106000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"special_numbering":"C","title":["Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non\u2013vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH\u2013AFNET 6) trial"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0197","authenticated-orcid":false,"given":"Paulus","family":"Kirchhof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin F.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Chlouverakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Christoph","family":"Diener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Huening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Simantirakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ahj.2017.04.015_bb0005","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/eurheartj\/ehs446","volume":"34","author":"Kirchhof","year":"2013","journal-title":"Eur Heart J"},{"issue":"38","key":"10.1016\/j.ahj.2017.04.015_bb0010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ahj.2017.04.015_bb0015","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2017.04.015_bb0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.04.015_bb0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ahj.2017.04.015_bb0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ahj.2017.04.015_bb0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ahj.2017.04.015_bb0040","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"10055","key":"10.1016\/j.ahj.2017.04.015_bb0045","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(16)31474-X","article-title":"Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial","volume":"388","author":"Goette","year":"2016","journal-title":"Lancet"},{"issue":"9921","key":"10.1016\/j.ahj.2017.04.015_bb0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ahj.2017.04.015_bb0055","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ahj.2017.04.015_bb0060","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ahj.2017.04.015_bb0065","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1161\/STROKEAHA.113.001884","article-title":"Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study","volume":"44","author":"Grond","year":"2013","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ahj.2017.04.015_bb0070","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.STR.0000131269.69502.d9","article-title":"Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack","volume":"35","author":"Jabaudon","year":"2004","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ahj.2017.04.015_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/europace\/eus366","article-title":"Prevalence of unknown atrial fibrillation in patients with risk factors","volume":"15","author":"Samol","year":"2013","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ahj.2017.04.015_bb0080","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCULATIONAHA.112.126656","article-title":"Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention","volume":"127","author":"Engdahl","year":"2013","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ahj.2017.04.015_bb0085","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation: the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"issue":"7616","key":"10.1016\/j.ahj.2017.04.015_bb0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","article-title":"Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial","volume":"335","author":"Fitzmaurice","year":"2007","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.ahj.2017.04.015_bb0095","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/eurheartj\/ehp235","article-title":"Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF","volume":"30","author":"Kirchhof","year":"2009","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2017.04.015_bb0100","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/STROKEAHA.112.654954","article-title":"Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke","volume":"43","author":"Rizos","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2017.04.015_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.111.676189","article-title":"Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors","author":"Ritter","year":"2013","journal-title":"Stroke"},{"issue":"26","key":"10.1016\/j.ahj.2017.04.015_bb0110","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ahj.2017.04.015_bb0115","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2017.04.015_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2017.04.015_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/europace\/eur241","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference","volume":"14","author":"Kirchhof","year":"2012","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.ahj.2017.04.015_bb0130","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahj.2017.04.015_bb0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10, 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2017.04.015_bb0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0735-1097(01)01351-1","article-title":"Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device","volume":"38","author":"Israel","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ahj.2017.04.015_bb0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.115.020252","article-title":"Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes","volume":"134","author":"Swiryn","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2017.04.015_bb0150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"26","key":"10.1016\/j.ahj.2017.04.015_bb0155","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ahj.2017.04.015_bb0160","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.hrthm.2015.07.007","article-title":"Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy","volume":"12","author":"Witt","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2017.04.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2017.04.015_bb0170","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2012.03.017","article-title":"Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT","volume":"9","author":"Kaufman","year":"2012","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ahj.2017.04.015_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCEP.109.877852","article-title":"Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation\u2014results of the XPECT trial","volume":"3","author":"Hindricks","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9586","key":"10.1016\/j.ahj.2017.04.015_bb0180","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ahj.2017.04.015_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2017.04.015_bb0190","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/STROKEAHA.109.571455","article-title":"Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events","volume":"41","author":"Ziegler","year":"2010","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.ahj.2017.04.015_bb0195","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm"},{"issue":"21","key":"10.1016\/j.ahj.2017.04.015_bb0200","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2017.04.015_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jce.12864","article-title":"Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) pilot study","volume":"27","author":"Passman","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"14","key":"10.1016\/j.ahj.2017.04.015_bb0210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/eurheartj\/ehv466","article-title":"XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation","volume":"37","author":"Camm","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.04.015_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw233","article-title":"Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF","author":"Bassand","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2017.04.015_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation","volume":"131","author":"Graham","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.04.015_bb0225","doi-asserted-by":"crossref","first-page":"i3189","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non\u2013vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study","volume":"353","author":"Larsen","year":"2016","journal-title":"BMJ"},{"issue":"7 Suppl.","key":"10.1016\/j.ahj.2017.04.015_bb0230","first-page":"S14","article-title":"Silent atrial fibrillation as a stroke risk factor and anticoagulation indication","volume":"29","author":"Glotzer","year":"2013","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2017.04.015_bb0235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccep.2015.05.010","article-title":"Management of device-detected atrial high-rate episodes","volume":"7","author":"Tomson","year":"2015","journal-title":"Card Electrophysiol Clin"},{"issue":"2","key":"10.1016\/j.ahj.2017.04.015_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/europace\/euw279","article-title":"Atrial high-rate episodes and stroke prevention","volume":"19","author":"Camm","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2017.04.015_bb0245","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ahj.2017.04.015_bb0250","doi-asserted-by":"crossref","first-page":"e110216","DOI":"10.1371\/journal.pone.0110216","article-title":"Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers","volume":"9","author":"Calvert","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ahj.2017.04.015_bb0255","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"9838","key":"10.1016\/j.ahj.2017.04.015_bb0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(12)60570-4","article-title":"Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial","volume":"380","author":"Kirchhof","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ahj.2017.04.015_bb0265","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2017.04.015_bb0270","first-page":"CD006186","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks","volume":"3","author":"Aguilar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.ahj.2017.04.015_bb0275","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2017.04.015_bb0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","article-title":"Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events","volume":"20","author":"Botto","year":"2009","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317301412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317301412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:47Z","timestamp":1757570327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317301412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":56,"alternative-id":["S0002870317301412"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.04.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non\u2013vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH\u2013AFNET 6) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}